Yang et al. revealed that CEP55 participated in SPAG5-mediated proliferation and migration of HCC cells and provided a viable therapeutic target for the clinical treatment of HCC (Yang et al., 2018). This evidence concerns the gene CEP55 and hepatocellular carcinoma.